Medline Inc. (MDLN) vs Solventum Corp (SOLV)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | MDLN | SOLV |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $28.43B | $8.32B |
| Revenue growth (YoY) | — | ▲ 0.9% |
| Net income | $1.16B | $1.56B |
| Gross margin | 26.4% | 53.5% |
| Diluted EPS | $-0.01 | $8.88 |
| Insider net (6 mo) | −960.8M sh • 86 sells • 1 buys | +116.8K sh • 0 sells • 0 buys |
| Institutional owners | 43 | 42 |
| Institutional value held | $13.15B | $5.32B |
| Next earnings (est.) | Around Nov 4, 2026 | Around Nov 5, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About Medline Inc. (MDLN)
Medline Inc., founded in 1966, is the largest provider of medical-surgical (med-surg) products and supply chain solutions serving all points of care, based on total net sales, delivering mission-critical products used daily across hospitals, surgery centers… Read more →
About Solventum Corp (SOLV)
Solventum Corporation is a global healthcare company that develops, manufactures, and commercializes a broad portfolio of solutions leveraging material science, data science, and digital capabilities to address customer and patient needs across the healthcare… Read more →
Source: SEC EDGAR.